Groowe Groowe / Newsroom / REGN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

REGN News

Regeneron Pharmaceuticals Inc

REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

accessnewswire.com
REGN

Join Class Action to Recover Losses From Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky Before September 14, 2026

accessnewswire.com
REGN

Pomerantz LLP Informs Shareholders of Securities Class Action Against Regeneron Pharmaceuticals, Inc. – REGN

accessnewswire.com
REGN

REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?

newsfilecorp.com
REGN

Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Recover Losses - Contact Levi & Korsinsky Before September 14, 2026

accessnewswire.com
REGN

Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight

globenewswire.com
BIIB HRMY XNCR AZN LLY PFE REGN NVS TSLA TAK GSK JNJ UCB BHF PRAX XENE AQST TNDM INCY MRK ABBV BMY AMGN GILD VRTX CRSP EDIT NTLA SRPT ALNY EXAS TEVA AXSM CYTK INSM KODK LPCN MNKD NBIX NCLH ONCY ORIC PBYI PEGA PLRX PRGS QGEN RGNX ROST RYAAY SNOW SWKS SYK TGT TRMB TXG ULTA VRSK WDC WVE XOM ZBRA ZNTL ZTS STOK IONS MOMO BBAR CTXR MBIO GNS NEON OVID BHVN

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP

prnewswire.com
REGN

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law

globenewswire.com
REGN

Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN

globenewswire.com
REGN

Amplifica Appoints Hans Hofland, Ph.D., as Chief Development Officer and William Humphries to Board of Directors

prnewswire.com
ACRS ALC AMGN BCRX BIIB BMY CRSP CTRA CYTK DASH EXAS GILD GSK INCY JNJ KDP LULU MRNA NBIX NVS OCGN ORCL PFE REGN ROST RVMD SNOW SRPT STRL TGTX TMO TRMB TSLA TXG VRTX XOM ZBRA